Learn more about Zenrelia from the experts
Find out more about how Zenrelia can help your patients through our expert led videos, podcasts and papers to support you in getting itchy dogs back to normal.
Expert Symposium on Zenrelia: A New Treatment to Elevate Care in Canine Allergic and Atopic Dermatitis.
Now you can share the excitement from London Vet Show and watch our expert symposium on Zenrelia.
Dr Victoria Robinson covers defining success in the management of atopic dermatitis, Dr Timothy Jones provides an introduction to Zenrelia and Dr Natalie Barnard shares her clinical experience of using Zenrelia in practice.
As featured in the Vet Times
Vet Times Extra:
Listen to the podcast on JAK inhibitors and veterinary dermatology with Dr Darren Berger.
Vet Times:
Find out more about getting dogs back to normal in our Vet Times article with Dr Timothy Jones.
Zenrelia Wins New Product of the Year!
Zenrelia™ has been awarded New Product of the Year at the recent Veterinary Marketing Awards (VMAs) as voted for by UK vets, reflecting its popularity in the UK and impact in the management of canine allergic and atopic dermatitis. Zenrelia also received several other awards at the VMAs, including the Exhibition Award for creating a stand-out space at London Vet Show.
Find out more about the success of Zenrelia at the VMA's here:
Further questions?
Additional Resources
Zenrelia™ contains ilunocitinib. Legal category POM-V in UK.
Further information can be found in the Summary of Product Characteristics. Use medicines responsibly (UK): APHA, NOAH. Advice should be sought from the prescriber prior to use. Prescription decisions are for the person issuing the prescription alone.
Zenrelia™, Elanco™ and the diagonal bar logo are trademarks of Elanco or its affiliates.
